Many pharmaceutical companies and medical device manufacturers fail to see how supply chain initiatives can help them overcome their most daunting barriers. This is especially true for players who have failed to embrace supply chain transformation as a way of moving from traditional operations to a model where desired outcomes define how every point on the chain is set up.
We recently completed a comprehensive Supply Chain Mastery study of capabilities and improvement opportunities associated with high performance in supply chain management. Over two years, we surveyed more than 1,500 executives in 21 countries and developed scores of cross-industry performance benchmarks.
The study clearly illustrates the cost-reducing, performance-enhancing role of logistics, while demonstrating that logistics excellence has different meanings and characteristics across industries.
In life sciences, we have identified six pillars of logistics mastery and discussed their potential benefits. We have also created capability maturity models (CMMs) for each category—a way for life sciences companies to measure their current status and begin forging a path to high performance.